Panitumumab-IRDye800 Clinical Trials

6 actively recruiting trials across 4 locations

Also known as: Panitumumab IRDye 800, RDye800-Panitumumab Conjugate, panitumumab-IRDye800CW

Filter by location:

Palo Alto, California3 trials

Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery

Stanford University, School of Medicine

Phase 1/2

Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

Stanford University School of Medicine

Phase 1/2

Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery

Stanford University, School of Medicine

Phase 1/2

Birmingham, Alabama1 trial

Phase II Panitumumab-IRDye800 in Head & Neck Cancer

University of Alabama at Birmingham

Phase 2

Stanford, California1 trial

Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures

Stanford Cancer Center

Phase 1/2

Nashville, Tennessee1 trial

Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer

Vanderbilt University/Ingram Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.